| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b5d728d4890268356fcc07e6e53840c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 |
| filingDate |
2006-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b54a8b44132fdc282b02f1df5c643346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62458bb062c404c65f74410c23f157d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f21645af4d58cee74af78f9b18e9d0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd86dbc316a5d92a353726a01c391b8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dc438d118fa78928900c713579075bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabba7c3bb729162d2eb7d4dea3d1a38 |
| publicationDate |
2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080047509-A |
| titleOfInvention |
Nanoparticulate Controlled Release Compositions Containing Platelet Aggregation Inhibitors |
| abstract |
The present invention relates to compositions containing platelet aggregation inhibitors such as cilostazol or salts or derivatives thereof useful for the treatment and prevention of ischemic syndrome. The present invention provides a composition comprising nanoparticulate particles containing a platelet aggregation inhibitor and at least one surface stabilizer. The nanoparticulate particles have an effective average particle size of less than about 2000 nm. The present invention also provides compositions for pulsatile or continuous delivery of platelet aggregation inhibitors, or platelet aggregation inhibitor-containing nanoparticles. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170061219-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101282847-B1 |
| priorityDate |
2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |